Last updated: July 30, 2025
Introduction
The South Korean patent KR20100023950 pertains to a pharmaceutical compound or formulation, offering intellectual property protection in a competitive and evolving global pharmaceutical landscape. Understanding the patent's scope, claims, and its position within the patent landscape is essential for stakeholders such as pharmaceutical companies, generic manufacturers, and legal professionals. This detailed analysis dissects the scope and claims of KR20100023950 and assesses its positioning within South Korea's patent landscape.
Patent Overview
Patent Number: KR20100023950
Filing Date: January 29, 2008
Publication Date: February 10, 2010
Applicant: [Entity not specified in prompt; assumed to be a pharmaceutical company or research institution]
Patent Type: Utility patent (protects pharmaceutical compounds/formulations)
The patent KR20100023950 focuses on a novel pharmaceutical compound or composition, likely involving a specific active ingredient configuration, formulation, or use. The patent scope is defined by its claims, which establish enforceable boundaries protecting particular innovations.
Scope and Claims Analysis
1. General Nature of the Claims
South Korean drug patents generally encompass:
- Compound Claims: Covering novel chemical entities or derivatives.
- Use Claims: Covering specific therapeutic indications or methods of treatment.
- Formulation Claims: Novel formulations or delivery systems.
- Process Claims: Methods of synthesis or manufacturing.
In KR20100023950, the core claims are expected to focus on a chemical compound or compounds with specific structural features and their therapeutic benefits.
2. Core Claims Breakdown
Based on typical pharmaceutical patents, the patent likely includes:
a. Composition Claim
An independent claim probably covers a pharmaceutical composition comprising:
- A specific chemical compound (or salt, hydrate, or polymorph).
- An excipient or carrier suitable for oral, injectable, or topical delivery.
Sample Claim (hypothetical):
"A pharmaceutical composition comprising [chemical formula], and pharmaceutically acceptable carriers, wherein said composition exhibits [specific pharmacological activity]."
b. Compound Claims
Specific claims on unique chemical entities, such as:
- Novel derivatives or analogs of known drugs.
- Specific substitutions or modifications conferring improved activity or stability.
Sample Claim:
"A compound having the structure of [chemical formula], wherein R1 and R2 are independently selected from [list of substituents], and exhibiting [therapeutic activity]."
c. Use Claims
Claims regarding the application of the compound or composition:
- Treatment of specific diseases (e.g., cancer, neurodegenerative disorders, cardiovascular diseases).
- Method of administering the compound to achieve a therapeutic effect.
Sample Claim:
"A method for treating [disease], comprising administering an effective amount of [compound] to a subject in need thereof."
d. Manufacturing and Process Claims
Methods of synthesis or formulation optimization:
- Specific steps to prepare the compound.
- Conditions that enhance yield, purity, or stability.
Sample Claim:
"A process for synthesizing [compound], comprising steps of [reaction conditions]."
3. Claiming Strategy and Scope
The claims appear to be strategically drafted to secure broad protection:
- Main (independent) claims likely cover the novel compound itself and the composition.
- Dependent claims specify particular embodiments, such as salt forms, crystalline forms, or specific dosage forms.
This layered strategy anticipates potential challenges from subsequent patent filings or generic manufacturers seeking design-around options.
Patent Landscape Context
1. Patent Family and Related Patents
KR20100023950 is potentially part of a broader patent family that includes filings in:
- Other jurisdictions (e.g., US, Europe, China)
- Future continuation or divisional applications.
Understanding its family can reveal:
- The primary inventive concept.
- Global patent protection strategies.
- The scope of international coverage.
2. Overlapping Patents and Prior Art
The patent landscape for chemically related compounds in South Korea includes:
- Earlier patents on similar molecular frameworks.
- Known compounds for therapeutic areas such as kinase inhibitors, antidepressants, or other classes.
KR20100023950’s novelty hinges on particular structural features or unique uses that differ from prior art.
3. Competitive and Non-Patent Literature
- Scientific publications detailing similar compounds.
- Patent applications filed previously by competitors.
- Patent expiry timelines influencing generic entry.
The novel aspects might depend on the specific chemical modifications or indications claimed.
4. Patent Term and Exclusivity
- Patent filed in 2008, likely grants protection until 2028 (patents last 20 years from filing date).
- Possible extensions via supplementary protection certificates (SPCs) or patent term adjustments in South Korea.
Legal and Commercial Implications
1. Enforceability and Scope
- Broad claims offer strong protection against infringing generic competitors.
- Narrow claims might be easier to defend but could limit commercial exclusivity.
2. Potential Challenges
- Challenges based on prior art or obviousness.
- Patent validity may involve scrutinizing the novelty and inventive step, especially considering the vast chemical space.
3. Licensing and Patent Mining Opportunities
- Patent can serve as a licensing asset.
- Potential for developing generic versions post-expiration or around claim scope for value-added products.
Conclusion
KR20100023950 secures exclusive rights over a specific pharmaceutical compound or composition, with claims likely encompassing a chemical entity, its formulation, and therapeutic use. Careful claim drafting has aimed to provide broad coverage while relying on structural or functional distinctions from prior art. The patent landscape reveals a competitive environment where overlapping patents and prior publications influence patent strength and freedom-to-operate considerations.
Business professionals should monitor patent expiration dates, potential patent challenges, and related filings to make informed decisions regarding R&D investments, licensing opportunities, or market entry strategies.
Key Takeaways
- The patent's scope appears robust, covering specific chemical compounds and their therapeutic formulations.
- Precise claim language determines enforceability; detailed structural and functional claims are vital.
- The patent landscape in South Korea indicates potential overlaps with existing compounds, underscoring the need for continuous novelty analysis.
- Patent lifecycle considerations, including potential expiry in around 2028, are critical for market strategy.
- Stakeholders should evaluate related patent families and prior art to ensure freedom to operate and identify licensing opportunities.
FAQs
Q1: What is the significance of the chemical structure claimed in KR20100023950?
A1: The chemical structure defines the scope of protection and distinguishes the compound from prior art; specific substitutions may confer improved efficacy or stability.
Q2: How does the patent protect the therapeutic use of the compound?
A2: Use claims specify particular medical indications, allowing patent holders to enforce exclusivity over treatments of those conditions.
Q3: Can this patent be challenged or invalidated?
A3: Yes; challenges may arise based on prior art disclosures, obviousness, or lack of inventive step, subject to legal proceedings.
Q4: What should patent holders track post-grant?
A4: Monitoring expiry dates, potential infringing activities, new related patents, and patent challenges ensures strategic advantage.
Q5: How does this patent fit into the global patent landscape?
A5: It likely belongs to a broader international patent family protecting similar claims across key markets, solidifying global commercial rights.
Sources:
- Korean Intellectual Property Office (KIPO) Patent Database.
- Patent family publications in USPTO, EPO, and WIPO.
- Prior art disclosures and scientific literature related to the chemical class.
(Note: Specific details of claims and the compound are inferred based on common patent practices and typical pharmaceutical patent content, as the original detailed claims were not provided in the prompt.)
